Treatment of Vitamin C Deficiency
For symptomatic vitamin C deficiency (scurvy), initiate oral vitamin C 100 mg three times daily (300-500 mg/day total) for at least one month, and do not delay treatment while awaiting laboratory confirmation if clinical symptoms are present. 1
Initial Treatment Approach
Oral Therapy (First-Line)
- Standard repletion dose: 100 mg three times daily OR 500 mg once daily for 1 month 1
- Alternative regimen for severe cases: 250 mg twice daily for 3 weeks 1
- Treatment should begin immediately when clinical symptoms suggest scurvy (bleeding gums, petechiae, ecchymosis, poor wound healing, perifollicular hemorrhages) 1, 2
- Do not wait for plasma vitamin C measurement results, as clinical trial of vitamin C should not be delayed in the presence of clinical symptoms 1
When Intravenous Therapy is Required
- IV administration is necessary when oral therapy fails to normalize levels or resolve symptoms despite adequate dosing 3
- Critical illness/acute inflammation: 2-3 g/day IV during the acute phase 1, 2
- Malabsorption syndromes: Consider IV route if enteral absorption is compromised (Crohn's disease, bariatric surgery, chronic diarrhea) 3, 4
- Oral absorption is limited at higher doses due to saturable intestinal transporters, making IV necessary in some refractory cases 2, 3
Maintenance Therapy After Repletion
Standard Maintenance
- Healthy adults: 75-90 mg/day (women 75 mg, men 90 mg) to prevent recurrence 2, 5
- Post-bariatric surgery: 200-500 mg/day may be required long-term 1
High-Risk Populations Requiring Higher Maintenance Doses
- Chronic oxidative stress conditions (diabetes, heart failure, smoking, alcoholism, severe COPD, chronic dialysis): 200-500 mg/day 1, 2
- Chronic malabsorption: Individualized dosing based on plasma levels and clinical response 1
- Continuous renal replacement therapy: 2-3 g/day IV 1, 2
Monitoring and Duration
Laboratory Testing
- Measure plasma vitamin C only in patients with clinical suspicion of scurvy or chronic low intake 1, 2
- Do NOT measure during critical illness or severe inflammation (CRP >10 mg/L), as results are unreliable and difficult to interpret 1, 2, 6
- Normal plasma vitamin C levels are typically not detected if CRP >40 mg/L 2
Treatment Duration
- Minimum 1 month for symptomatic deficiency 1
- 3 weeks for clinical scurvy with the 250 mg twice-daily regimen 1
- Continue until clinical symptoms resolve and adequate dietary intake is established 1, 4
Safety Considerations and Contraindications
Absolute Contraindications
- Hemochromatosis or iron overload: Vitamin C enhances iron absorption 2, 7
- G6PD deficiency: Risk of hemolysis with high doses 2, 6
- Active oxalate kidney stones: High doses increase oxalate excretion 2, 6
- Severe renal dysfunction: Risk of oxalate accumulation 2, 6
Adverse Effects
- Gastrointestinal upset: Doses >2 g/day may cause diarrhea and abdominal discomfort 5, 8
- Tolerable upper limit: 2 g/day based on GI side effects 5, 8
- High doses (>1 g/day) are generally safe but require monitoring for edema 6
Common Pitfalls to Avoid
- Delaying treatment: Do not wait for laboratory confirmation when clinical scurvy is suspected—start empiric therapy immediately 1, 2
- Inadequate dosing: The 40-45 mg/day threshold prevents scurvy but does not achieve tissue adequacy or optimal repletion 2
- Ignoring malabsorption: Patients with inflammatory bowel disease, bariatric surgery, or chronic diarrhea may require IV therapy despite adequate oral dosing 3, 4
- Single high-dose strategy: Dividing total daily dose into multiple administrations (e.g., 100 mg TID rather than 300 mg once daily) maximizes absorption due to saturable intestinal transporters 2, 7
- Measuring levels during inflammation: Plasma vitamin C declines rapidly with inflammation, making interpretation unreliable in acute illness 1, 2, 6
- Assuming dietary intake is sufficient: Modern food production, transport, and storage severely impair vitamin C content, making supplementation often necessary even with adequate fruit/vegetable intake 9